The development of the HIV infection-preventing drug lenacapavir is the most important research development of 2024, Science ...

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.

LOS ANGELES, Dec. 13 (Xinhua) -- An injectable HIV drug with novel mechanism was named on Thursday by the influential U.S. journal "Science" as Breakthrough of the Year. The drug, named lenacapavir, ...

Lenacapavir, a treatment administered subcutaneously every six months, is capable of preventing infection with very high ...

Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.

Science, a global scientific journal, has selected lenacapavir (lenacapavir), a groundbreaking HIV infection treatment, and related studies for the '2024 Innovation of the Year'. Renacapavir, an ...

The pupils of Fangcaodi International School, a state-run primary school in Beijing with an emphasis on science education, have closely followed China’s recent lunar endeavours. In June ...

December 9, 2024 • It's that time of the year when you're making your list, checking it twice, for gifts that spark a love of science for the kids in your life. Ira talks with Mahnaz Dar ...